206,550 Baxter International Inc. $BAX Shares Sold by RWC Asset Management LLP

Key Points

• RWC Asset Management reduced its Baxter International stake by 6.2%, selling 206,550 shares in the third quarter but retaining 3.12 million shares valued at approximately $74.9 million. Institutional investors collectively own 90.19% of Baxter’s stock.
• Baxter reported quarterly earnings of $0.56 per share, exceeding estimates of $0.37, while revenue reached $2.96 billion and grew 5.3% year over year. The company guided for fiscal 2026 EPS of $1.95 to $2.15.
• Analyst sentiment remains cautious: Baxter has an average “Reduce” rating and a consensus price target of $21.73, below its reported trading price of $25.32. The company also declared a quarterly dividend of $0.01 per share, representing a 0.2% annualized yield.

RWC Asset Management LLP lessened its holdings in Baxter International Inc. (NYSE:BAX - Free Report) by 6.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,122,618 shares of the medical instruments supplier's stock after selling 206,550 shares during the quarter. Baxter International makes up approximately 2.8% of RWC Asset Management LLP's investment portfolio, making the stock its 6th largest position. RWC Asset Management LLP owned 0.60% of Baxter International worth $74,943,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Jones Financial Companies Lllp bought a new stake in Baxter International during the 2nd quarter worth approximately $26,000. CYBER HORNET ETFs LLC lifted its holdings in shares of Baxter International by 52.4% during the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier's stock worth $46,000 after purchasing an additional 740 shares during the period. Community Bank N.A. acquired a new position in shares of Baxter International during the second quarter worth $46,000. Versant Capital Management Inc lifted its holdings in shares of Baxter International by 552.2% during the second quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier's stock worth $51,000 after purchasing an additional 2,043 shares during the period. Finally, EFG International AG bought a new stake in shares of Baxter International in the second quarter worth $67,000. Institutional investors own 90.19% of the company's stock.

Baxter International Trading Down 1.3%

Shares of Baxter International stock traded down $0.33 on Friday, hitting $25.32. 4,936,022 shares of the company's stock traded hands, compared to its average volume of 6,154,588. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.95 and a quick ratio of 1.32. The company has a fifty day moving average of $24.76 and a two-hundred day moving average of $22.15. The company has a market capitalization of $13.09 billion, a price-to-earnings ratio of -12.23, a price-to-earnings-growth ratio of 3.88 and a beta of 0.65.

Baxter International (NYSE:BAX - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. The firm had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The company's revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, sell-side analysts expect that Baxter International Inc. will post 2.04 earnings per share for the current year.

Baxter International Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 1st. Investors of record on Friday, August 28th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, August 28th. Baxter International's dividend payout ratio is -1.93%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on BAX. Citigroup lowered their target price on Baxter International from $28.00 to $27.00 and set a "neutral" rating for the company in a research report on Monday, October 5th. Wells Fargo & Company lifted their target price on Baxter International from $19.00 to $23.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. TD Cowen upped their price target on Baxter International from $20.00 to $24.00 and gave the company a "hold" rating in a research report on Monday, July 27th. Zacks Research raised Baxter International from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 11th. Finally, The Goldman Sachs Group raised their price objective on Baxter International from $19.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 15th. One investment analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Reduce" and an average price target of $21.73.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter's portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.